By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Dynamic Business Location.

Zika Virus: Testing for Austria vaccine begins

logo Themis © Themis

The clinical study will focus on identifying the most suitable doses of the vaccine candidate in regard to immunogenicity, safety, and tolerability. Therefore up to 48 healthy volunteers will participate in the study and three different treatment regimens will be compared with a placebo treatment. One treatment group will receive one injection of high dose vaccine, the other two groups will receive two shots of either high dose or low dose vaccine. Results of all groups are expected within the next six months. The study will be conducted at the "Department of Clinical Pharmacology" and the "Institute of Specific Prophylaxis and Tropical Medicine" at the Medical University of Vienna, Austria.

Zika is a viral infection transmitted by mosquitoes. It originates in Asia and parts of Africa but the increase in global traveling and rising temperatures may cause it to spread into more temperate zones. Recently, the virus spread across the Pacific Ocean to the Americas, leading to the 2015/16 virus epidemic.

About Themis

Themis Bioscience GmbH develops prophylactic vaccines from the preclinical to the early clinical phase, focusing on emerging tropical infectious diseases, with initial vaccine candidates currently being developed against Chikungunya and Zika. The company's highly innovative and fully patent-protected measles virus vaccine vector technology platform, licensed from the internationally respected Institut Pasteur in Paris, forms the basis for all current vaccine candidates of the Vienna-based company.
www.themisbio.com

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Ukrainian-Austrian Business Forum

    27.4.2021/ 14.00 (CET) , Online Conference

  • Meet us @ Open Vienna - A Thriving Startup Ecosystem

    28.04.2021/ 9.15 am - 1.30 pm (CET), Online Conference

Austria Map

Find the perfect location for your company

We are lucky to benefit from a lot of reserach incentives here in Austria. We are very proud to be here as Austria is an ideal location for research.

TachoEASY Austria

Logo
More testimonials

news from the business location Austria

Medical University of Vienna and Vienna General Hospital: Expertise for lung transplants in cases of COVID-19

In May 2020, a team led by thoracic surgeon Konrad Hoetzenecker of the Department of Surgery of the Medical University of Vienna (MedUni Vienna) and Vienna General Hospital performed a lung transplant on a 44-year-old patient who had been seriously ill with COVID-19, making her the first patient in Europe to receive a lung transplant for this indication.

Shared Mobility in Austria!

"A green planet with mobility from everyone, for everyone" has continuously been the motto of GO Sharing.

More news All blog posts